Beam Therapeutics (BEAM) announced the appointment of Sravan Emany as CFO, effective December 19, 2024. He most recently served as CFO and COO at Ironwood Pharmaceuticals (IRWD)
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics Strengthens Board with Pharma Veteran
- Beam Therapeutics appoints Guindo to its board of directors
- Beam Therapeutics management to meet virtually with Cantor Fitzgerald
- Beam Therapeutics participates in a conference call with JPMorgan
- Beam Therapeutics upgraded to Outperform from Market Perform at Leerink